The CLN3 gene and protein: What we know

Abstract Background One of the most important steps taken by Beyond Batten Disease Foundation in our quest to cure juvenile Batten (CLN3) disease is to understand the State of the Science. We believe that a strong understanding of where we are in our experimental understanding of the CLN3 gene, its...

Full description

Bibliographic Details
Main Authors: Myriam Mirza, Anna Vainshtein, Alberto DiRonza, Uma Chandrachud, Luke J. Haslett, Michela Palmieri, Stephan Storch, Janos Groh, Niv Dobzinski, Gennaro Napolitano, Carolin Schmidtke, Danielle M. Kerkovich
Format: Article
Language:English
Published: Wiley 2019-12-01
Series:Molecular Genetics & Genomic Medicine
Subjects:
Online Access:https://doi.org/10.1002/mgg3.859
id doaj-ff6be28e0b18473a86341a67a5838308
record_format Article
spelling doaj-ff6be28e0b18473a86341a67a58383082020-11-25T01:20:43ZengWileyMolecular Genetics & Genomic Medicine2324-92692019-12-01712n/an/a10.1002/mgg3.859The CLN3 gene and protein: What we knowMyriam Mirza0Anna Vainshtein1Alberto DiRonza2Uma Chandrachud3Luke J. Haslett4Michela Palmieri5Stephan Storch6Janos Groh7Niv Dobzinski8Gennaro Napolitano9Carolin Schmidtke10Danielle M. Kerkovich11Mila’s Miracle Foundation Boulder ColoradoCraft Science Inc. Thornhill CanadaBaylor College of Medicine Houston TexasCenter for Genomic Medicine Massachusetts General Hospital/Harvard Medical School Boston MassachusettsSchool of Biosciences Cardiff University Cardiff UKBaylor College of Medicine Houston TexasBiochemistry University Medical Center Hamburg‐Eppendorf Hamburg GermanyNeurology University Hospital Wuerzburg Wuerzburg GermanyBiochemistry and Biophysics UCSF School of Medicine San Francisco CaliforniaTelethon Institute of Genetics and Medicine Napoli ItalyBiochemistry University Medical Center Hamburg‐Eppendorf Hamburg GermanyBeyond Batten Disease Foundation Austin TexasAbstract Background One of the most important steps taken by Beyond Batten Disease Foundation in our quest to cure juvenile Batten (CLN3) disease is to understand the State of the Science. We believe that a strong understanding of where we are in our experimental understanding of the CLN3 gene, its regulation, gene product, protein structure, tissue distribution, biomarker use, and pathological responses to its deficiency, lays the groundwork for determining therapeutic action plans. Objectives To present an unbiased comprehensive reference tool of the experimental understanding of the CLN3 gene and gene product of the same name. Methods BBDF compiled all of the available CLN3 gene and protein data from biological databases, repositories of federally and privately funded projects, patent and trademark offices, science and technology journals, industrial drug and pipeline reports as well as clinical trial reports and with painstaking precision, validated the information together with experts in Batten disease, lysosomal storage disease, lysosome/endosome biology. Results The finished product is an indexed review of the CLN3 gene and protein which is not limited in page size or number of references, references all available primary experiments, and does not draw conclusions for the reader. Conclusions Revisiting the experimental history of a target gene and its product ensures that inaccuracies and contradictions come to light, long‐held beliefs and assumptions continue to be challenged, and information that was previously deemed inconsequential gets a second look. Compiling the information into one manuscript with all appropriate primary references provides quick clues to which studies have been completed under which conditions and what information has been reported. This compendium does not seek to replace original articles or subtopic reviews but provides an historical roadmap to completed works.https://doi.org/10.1002/mgg3.859BattenCLN3JNCLjuvenile Battenneuronal ceroid lipofuscinosis
collection DOAJ
language English
format Article
sources DOAJ
author Myriam Mirza
Anna Vainshtein
Alberto DiRonza
Uma Chandrachud
Luke J. Haslett
Michela Palmieri
Stephan Storch
Janos Groh
Niv Dobzinski
Gennaro Napolitano
Carolin Schmidtke
Danielle M. Kerkovich
spellingShingle Myriam Mirza
Anna Vainshtein
Alberto DiRonza
Uma Chandrachud
Luke J. Haslett
Michela Palmieri
Stephan Storch
Janos Groh
Niv Dobzinski
Gennaro Napolitano
Carolin Schmidtke
Danielle M. Kerkovich
The CLN3 gene and protein: What we know
Molecular Genetics & Genomic Medicine
Batten
CLN3
JNCL
juvenile Batten
neuronal ceroid lipofuscinosis
author_facet Myriam Mirza
Anna Vainshtein
Alberto DiRonza
Uma Chandrachud
Luke J. Haslett
Michela Palmieri
Stephan Storch
Janos Groh
Niv Dobzinski
Gennaro Napolitano
Carolin Schmidtke
Danielle M. Kerkovich
author_sort Myriam Mirza
title The CLN3 gene and protein: What we know
title_short The CLN3 gene and protein: What we know
title_full The CLN3 gene and protein: What we know
title_fullStr The CLN3 gene and protein: What we know
title_full_unstemmed The CLN3 gene and protein: What we know
title_sort cln3 gene and protein: what we know
publisher Wiley
series Molecular Genetics & Genomic Medicine
issn 2324-9269
publishDate 2019-12-01
description Abstract Background One of the most important steps taken by Beyond Batten Disease Foundation in our quest to cure juvenile Batten (CLN3) disease is to understand the State of the Science. We believe that a strong understanding of where we are in our experimental understanding of the CLN3 gene, its regulation, gene product, protein structure, tissue distribution, biomarker use, and pathological responses to its deficiency, lays the groundwork for determining therapeutic action plans. Objectives To present an unbiased comprehensive reference tool of the experimental understanding of the CLN3 gene and gene product of the same name. Methods BBDF compiled all of the available CLN3 gene and protein data from biological databases, repositories of federally and privately funded projects, patent and trademark offices, science and technology journals, industrial drug and pipeline reports as well as clinical trial reports and with painstaking precision, validated the information together with experts in Batten disease, lysosomal storage disease, lysosome/endosome biology. Results The finished product is an indexed review of the CLN3 gene and protein which is not limited in page size or number of references, references all available primary experiments, and does not draw conclusions for the reader. Conclusions Revisiting the experimental history of a target gene and its product ensures that inaccuracies and contradictions come to light, long‐held beliefs and assumptions continue to be challenged, and information that was previously deemed inconsequential gets a second look. Compiling the information into one manuscript with all appropriate primary references provides quick clues to which studies have been completed under which conditions and what information has been reported. This compendium does not seek to replace original articles or subtopic reviews but provides an historical roadmap to completed works.
topic Batten
CLN3
JNCL
juvenile Batten
neuronal ceroid lipofuscinosis
url https://doi.org/10.1002/mgg3.859
work_keys_str_mv AT myriammirza thecln3geneandproteinwhatweknow
AT annavainshtein thecln3geneandproteinwhatweknow
AT albertodironza thecln3geneandproteinwhatweknow
AT umachandrachud thecln3geneandproteinwhatweknow
AT lukejhaslett thecln3geneandproteinwhatweknow
AT michelapalmieri thecln3geneandproteinwhatweknow
AT stephanstorch thecln3geneandproteinwhatweknow
AT janosgroh thecln3geneandproteinwhatweknow
AT nivdobzinski thecln3geneandproteinwhatweknow
AT gennaronapolitano thecln3geneandproteinwhatweknow
AT carolinschmidtke thecln3geneandproteinwhatweknow
AT daniellemkerkovich thecln3geneandproteinwhatweknow
AT myriammirza cln3geneandproteinwhatweknow
AT annavainshtein cln3geneandproteinwhatweknow
AT albertodironza cln3geneandproteinwhatweknow
AT umachandrachud cln3geneandproteinwhatweknow
AT lukejhaslett cln3geneandproteinwhatweknow
AT michelapalmieri cln3geneandproteinwhatweknow
AT stephanstorch cln3geneandproteinwhatweknow
AT janosgroh cln3geneandproteinwhatweknow
AT nivdobzinski cln3geneandproteinwhatweknow
AT gennaronapolitano cln3geneandproteinwhatweknow
AT carolinschmidtke cln3geneandproteinwhatweknow
AT daniellemkerkovich cln3geneandproteinwhatweknow
_version_ 1725132450809511936